Huadong Chen
9PUBLICATIONS
44CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Nov 26, 2025
Identification of a Two-Gene Biomarker Correlated with Sensitivity to Combined PARP7 Inhibition and AHR Activation in Cancer Cells.Xuxu Gou, Huadong Chen, Morgan E Diolaiti
|Nov 19, 2025
The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2.Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy
|Sep 24, 2024
PARP7 Inhibitors and AHR Agonists Act Synergistically across a Wide Range of Cancer Models.Huadong Chen, Xuxu Gou, Ying Mao
|Jan 18, 2023
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance.Li-Min Wang, Pingyuan Wang, Xiao-Min Chen
|Oct 23, 2022
Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2.Patrick C O'Leary, Huadong Chen, Yagmur U Doruk
|Apr 19, 2022
A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor.Huadong Chen, Morgan E Diolaiti, Patrick C O'Leary
Pageof 2
Frequent Collaborators
5 joint publications
Morgan E Diolaiti
4 joint publications
Alan Ashworth
4 joint publications
Patrick C O'Leary
3 joint publications
Nevan J Krogan
2 joint publications
Ze-Hong Miao
2 joint publications
Jin-Xue He
2 joint publications
Xuxu Gou
2 joint publications
Danielle L Swaney
2 joint publications
Minkyu Kim
1 joint publications
Hui Yang
